Improving access to novel COVID-19 treatments
A briefing to Member States on how to navigate interfaces between public health and intellectual property
11 April 2023
| Technical document
Overview
This briefing document is a factual explanation of some of the legal instruments that Member States are
allowed to use to promote public health and access to key therapeutics, in the framework of their multilateral trade obligations and rights and according to their national legislations and level of development.
WHO Team
Health Product Policy and Standards (HPS),
Medicines Selection, IP and Affordability (MIA)
Editors
Prepared by Unitaid and WHO
With the support of Medicines Law & Policy
Number of pages
40